Retatrutide

Retatrutide is a cutting-edge investigational peptide designed as a triple agonist targeting GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors.

Note: Retatrutide is intended for research purposes only and is not approved for human consumption or use. All products are shipped in lyophilized form and must be reconstituted to a liquid for research and testing.  We are unable to provide any dosing instructions. All products should be considered pharmaceutical grade.